Dual blockade immunotherapy targeting PD-1/PD-L1 and CTLA-4 in lung cancer
Abstract Cancer immunotherapies, represented by immune checkpoint inhibitors (ICIs), have reshaped the treatment paradigm for both advanced non-small cell lung cancer and small cell lung cancer. Programmed death receptor-1/programmed death receptor ligand-1 (PD-1/PD-L1) and cytotoxic T lymphocyte-as...
Salvato in:
| Autori principali: | , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BMC
2024-07-01
|
| Serie: | Journal of Hematology & Oncology |
| Soggetti: | |
| Accesso online: | https://doi.org/10.1186/s13045-024-01581-2 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|